Pablo G. Legorreta

Insider Reports History

Location
New York, NY
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Pablo G. Legorreta
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pablo G. Legorreta:

Company Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc CEO, Chairman of the Board, Director LP interests in RPI US Partners 2019, LP 3,707,488 $1,328,763,699 $358.40 06 Aug 2025 By Legorreta Investments LLC
Royalty Pharma plc CEO, Chairman of the Board, Director LP interests in RPI US Partners 2019, LP 1,832,363 $656,718,899 $358.40 06 Aug 2025 By Legorreta Investments II LLC
Royalty Pharma plc CEO, Chairman of the Board, Director Class B Ordinary Shares 9,700,000 $309,915,000 $31.95 12 May 2025 By PL RPH AIV, LLC
PROKIDNEY CORP. Director, 10%+ Owner Class B Ordinary Shares 84,283,430 $248,489,374 $2.82 03 Jun 2025 Indirect
Royalty Pharma plc CEO, Chairman of the Board, Director LP interests in RPI US Partners 2019, LP 692,701 $248,264,038 $358.40 08 Aug 2025 Direct
PROKIDNEY CORP. Director, 10%+ Owner Common Units in ProKidney LP 84,283,430 $73,326,584 $0.8700 03 Jun 2025 Indirect
PROKIDNEY CORP. Director, 10%+ Owner Class A Ordinary Shares 22,617,909 $54,735,340 $2.42 13 Jun 2024 Indirect
Royalty Pharma plc CEO, Chairman of the Board, Director LP interests in RPI US Partners 2019, LP 147,014 $52,689,817 $358.40 06 Aug 2025 By Spouse
Royalty Pharma plc CEO, Chairman of the Board, Director Class A Ordinary Shares 1,098,783 $42,456,975 $38.64 11 Feb 2026 Direct
Royalty Pharma plc CEO, Chairman of the Board, Director Class A Ordinary Shares 1,040,410 $40,201,442 $38.64 11 Feb 2026 By Legorreta Children 2002 Trust
Royalty Pharma plc CEO, Chairman of the Board, Director Class A Ordinary Shares 901,590 $34,837,437 $38.64 11 Feb 2026 By GST-Exempt Legorreta 2012 Family Trust
Royalty Pharma plc CEO, Chairman of the Board, Director Class A Ordinary Shares 600,000 $23,184,000 $38.64 11 Feb 2026 By Legorreta 2023 SR Trust
PROKIDNEY CORP. Director, 10%+ Owner Class A Ordinary Shares 22,617,909 $19,677,580 $0.8700 03 Jun 2025 Indirect
Royalty Pharma plc CEO, Chairman of the Board, Director Class A Ordinary Shares 460,139 $17,779,770 $38.64 11 Feb 2026 By Legorreta Investments LLC
Royalty Pharma plc CEO, Chairman of the Board, Director Class A Ordinary Shares 292,190 $11,290,221 $38.64 11 Feb 2026 By Tata MC 35 Ltd.
Royalty Pharma plc CEO, Chairman of the Board, Director Class A Ordinary Shares 123,310 $4,764,698 $38.64 11 Feb 2026 By IRRA
Royalty Pharma plc CEO, Chairman of the Board, Director Class A Ordinary Shares 118,500 $4,578,840 $38.64 11 Feb 2026 By SEP/IRA
Royalty Pharma plc CEO, Chairman of the Board, Director Class A Ordinary Shares 41,306 $1,596,063 $38.64 11 Feb 2026 By GST-Exempt Legorreta 2020 Family Trust
Royalty Pharma plc CEO, Chairman of the Board, Director Class A Ordinary Shares 10,000 $386,400 $38.64 11 Feb 2026 By Daughter
Royalty Pharma plc CEO, Chairman of the Board, Director Class A Ordinary Shares 10,000 $386,400 $38.64 11 Feb 2026 By Son
Royalty Pharma plc CEO, Chairman of the Board, Director Class A Ordinary Shares 6,930 $267,775 $38.64 11 Feb 2026 By Spouse
Royalty Pharma plc CEO, Chairman of the Board, Director Class B Ordinary Shares 0 $0 $31.95 12 May 2025 By Spouse
Royalty Pharma plc CEO, Chairman of the Board, Director Class B Ordinary Shares 0 $0 $31.95 12 May 2025 Direct
Royalty Pharma plc CEO, Chairman of the Board, Director Class E Ordinary Shares 13,356,742 16 May 2025 By PL RPH Holdings, LLC
Royalty Pharma plc CEO, Chairman of the Board, Director Option (Right to Buy) 857,138 16 May 2025 By PL RPH Holdings, LLC
PROKIDNEY CORP. Director, 10%+ Owner Director stock option (right to buy) 125,862 29 May 2025 Direct
Epizyme, Inc. Director, 10%+ Owner Common Stock, par value $0.0001 0 $1.41 12 Aug 2022 Indirect
Epizyme, Inc. Director, 10%+ Owner Restricted Stock Units 0 12 Aug 2022 Direct

Insider Reports Filed by Pablo G. Legorreta

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RPRX Royalty Pharma plc 11 Feb 2026 1 $0 4 CEO, Chairman of the Board, Director 13 Feb 2026, 16:03
RPRX Royalty Pharma plc 05 Nov 2025 1 $0 4 CEO, Chairman of the Board, Director 07 Nov 2025, 16:19
RPRX Royalty Pharma plc 06 Aug 2025 2 $0 4 CEO, Chairman of the Board, Director 08 Aug 2025, 17:00
PROK PROKIDNEY CORP. 03 Jun 2025 4 $0 4 Director, 10%+ Owner 05 Jun 2025, 16:15
PROK PROKIDNEY CORP. 29 May 2025 1 $0 4 Director, 10%+ Owner 02 Jun 2025, 16:15
RPRX Royalty Pharma plc 16 May 2025 3 $0 4 CEO, Chairman of the Board, Director 20 May 2025, 16:49
RPRX Royalty Pharma plc 12 May 2025 2 $0 4 CEO, Chairman of the Board, Director 14 May 2025, 17:02
RPRX Royalty Pharma plc 08 May 2025 1 $0 4 CEO, Chairman of the Board, Director 09 May 2025, 17:18
PROK PROKIDNEY CORP. 04 Feb 2025 4 $0 4 Director, 10%+ Owner 06 Feb 2025, 17:02
PROK PROKIDNEY CORP. 13 Jun 2024 1 +$54,735,340 4 Director, 10%+ Owner 14 Jun 2024, 16:05
PROK PROKIDNEY CORP. 30 May 2024 1 $0 4 Director 03 Jun 2024, 16:33
PROK PROKIDNEY CORP. 05 Feb 2024 4 $0 4 Director, 10%+ Owner 06 Feb 2024, 16:05
PROK PROKIDNEY CORP. 30 Oct 2023 4 $0 4 Director, 10%+ Owner 01 Nov 2023, 17:27
PROK PROKIDNEY CORP. 29 Jun 2023 1 $0 4 Director, 10%+ Owner 03 Jul 2023, 09:16
RPRX Royalty Pharma plc 28 Jun 2023 1 +$3,836,768 4 CEO, Chairman of the Board, Director, 10%+ Owner 28 Jun 2023, 16:01
RPRX Royalty Pharma plc 12 Jun 2023 2 +$2,959,848 4 CEO, Chairman of the Board, Director, 10%+ Owner 13 Jun 2023, 16:01
RPRX Royalty Pharma plc 24 May 2023 1 +$4,837,440 4 CEO, Chairman of the Board, Director, 10%+ Owner 24 May 2023, 18:45
RPRX Royalty Pharma plc 16 May 2023 2 +$7,676,824 4 CEO, Chairman of the Board, Director, 10%+ Owner 17 May 2023, 18:41
RPRX Royalty Pharma plc 12 May 2023 2 $0 4 CEO, Chairman of the Board, Director, 10%+ Owner 15 May 2023, 21:34
RPRX Royalty Pharma plc 31 Dec 2022 1 $0 5 CEO, Chairman of the Board, Director, 10%+ Owner 10 Feb 2023, 18:48
RPRX Royalty Pharma plc 30 Dec 2022 2 $0 4 CEO, Chairman of the Board, Director, 10%+ Owner 16 Nov 2023, 17:50
/report/000089924322028860-legorreta-pablo-g-2022-08-12 Epizyme, Inc. 12 Aug 2022 3 $0 4 Director, 10%+ Owner 16 Aug 2022, 18:55
PROK PROKIDNEY CORP. 11 Jul 2022 3 $0 4 Director, 10%+ Owner 13 Jul 2022, 21:30
PROK PROKIDNEY CORP. 11 Jul 2022 0 $0 3 Director, 10%+ Owner 13 Jul 2022, 21:06
/report/000089924322018914-legorreta-pablo-g-2022-05-17 Epizyme, Inc. 17 May 2022 2 +$22,963 4 Director, 10%+ Owner 19 May 2022, 18:01
/report/000089924322003857-legorreta-pablo-g-2022-01-31 Epizyme, Inc. 31 Jan 2022 1 +$34,000,000 4 Director, 10%+ Owner 01 Feb 2022, 15:17
/report/000089924321023897-legorreta-pablo-g-2021-06-11 Epizyme, Inc. 11 Jun 2021 2 +$345,968 4 Director, 10%+ Owner 15 Jun 2021, 17:14
RPRX Royalty Pharma plc 07 May 2021 4 $0 4 CEO, Chairman of the Board, Director 11 May 2021, 21:03
RPRX Royalty Pharma plc 16 Jun 2020 13 $0 4 CEO, Chairman of the Board, Director, 10%+ Owner 15 Apr 2022, 18:55
RPRX Royalty Pharma plc 15 Jun 2020 1 $0 4/A CEO, Chairman of the Board, Director, 10%+ Owner 15 Apr 2022, 18:49
RPRX Royalty Pharma plc 15 Jun 2020 0 $0 3/A CEO, Chairman of the Board, Director 15 Apr 2022, 18:45